- Home
- FFWM vs ORIC Comparison
FFWM vs ORIC Comparison
Compare FFWM & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFWM
- ORIC
- Stock Information
- Founded
- FFWM 1990
- ORIC 2014
- Country
- FFWM United States
- ORIC United States
- Employees
- FFWM N/A
- ORIC N/A
- Industry
- FFWM Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- FFWM Finance
- ORIC Health Care
- Exchange
- FFWM Nasdaq
- ORIC Nasdaq
- Market Cap
- FFWM 510.5M
- ORIC 633.7M
- IPO Year
- FFWM 2014
- ORIC 2020
- Fundamental
- Price
- FFWM $6.24
- ORIC $10.33
- Analyst Decision
- FFWM Buy
- ORIC Strong Buy
- Analyst Count
- FFWM 4
- ORIC 9
- Target Price
- FFWM $6.75
- ORIC $18.75
- AVG Volume (30 Days)
- FFWM 416.2K
- ORIC 601.8K
- Earning Date
- FFWM 01-30-2025
- ORIC 03-10-2025
- Dividend Yield
- FFWM 0.32%
- ORIC N/A
- EPS Growth
- FFWM N/A
- ORIC N/A
- EPS
- FFWM N/A
- ORIC N/A
- Revenue
- FFWM $108,182,000.00
- ORIC N/A
- Revenue This Year
- FFWM N/A
- ORIC N/A
- Revenue Next Year
- FFWM $31.36
- ORIC N/A
- P/E Ratio
- FFWM N/A
- ORIC N/A
- Revenue Growth
- FFWM N/A
- ORIC N/A
- 52 Week Low
- FFWM $4.84
- ORIC $6.33
- 52 Week High
- FFWM $10.72
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- FFWM 47.08
- ORIC 59.58
- Support Level
- FFWM $6.03
- ORIC $9.69
- Resistance Level
- FFWM $6.46
- ORIC $11.15
- Average True Range (ATR)
- FFWM 0.25
- ORIC 0.82
- MACD
- FFWM 0.08
- ORIC 0.18
- Stochastic Oscillator
- FFWM 75.98
- ORIC 75.08
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.